Stifel Nicolaus analyst J. Parker Lane maintained a Hold rating on Sprinklr (CXM – Research Report) today and set a price target of $10.00. The ...

Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of ...

Stifel Financial Corp (NYSE:SF). has announced a revision to its executive compensation structure, according to a recent SEC filing. On Monday, the Compensation Committee of the Board of Directors ...

Matson, Inc. (NYSE: MATX) announced today that Matt Cox, Chairman and Chief Executive Officer will be attending the Stifel 2025 Transportation & Logistics Conference to be held on February 11, 2025 in ...

Stifel Financial (SF) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue ...

Amdocs increased its dividend and enhanced margins by cutting low-margin businesses. Learn why DOX stock shows strong ...

Real Brokerage is reshaping the residential real estate industry with a technology-driven approach designed to empower agents and simplify home transactions. At the heart of Real’s strategy is ...

We’ve examined the best brokers based on characteristics that matter to individual investors, including trading fees, account minimums, free research and many other features. We’ve evaluated ...

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in ...